Financial and risk advisor Kroll Australia has deemed family office Lederer Group’s offer to acquire listed Elanor Commercial ...
Trump’s pharmaceutical tariffs threaten a $2 billion export industry and test Australia’s resolve to defend its Pharmaceutical Benefits Scheme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback